Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ventimiglia, M.
~ 300  Ergebnisse:
Personensuche X
?
1

P908 Real-life effectiveness and safety of tofacitinib and ..:

Noviello, D ; Savarino, E ; Fries, W...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1660-i1661 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P539 Assessment of VEdolizumab aNd Ustekinumab in Elderly p..:

Viola, A ; Ventimiglia, M ; Sparacino, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1059-i1061 , 2024
Link: https://doi.org/10.1093/..
 
?
3

OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDER..:

Viola, A. ; Ventimiglia, M. ; Sparacino, A....
Digestive and Liver Disease.  56 (2024)  - p. S161-S163 , 2024
Link: https://doi.org/10.1016/..
 
?
4

P396 Ustekinumab Is A Promising Option For The Treatment Of..:

Macaluso, F S ; Grova, M ; Mocciaro, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i528-i528 , 2023
Link: https://doi.org/10.1093/..
 
?
5

T.06.2 USTEKINUMAB IS A PROMISING OPTION FOR THE TREATMENT ..:

Macaluso, F.S. ; Grova, M. ; Mocciaro, F....
Digestive and Liver Disease.  55 (2023)  - p. S159-S160 , 2023
Link: https://doi.org/10.1016/..
 
?
6

OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATI..:

Macaluso, F.S. ; Principi, M. ; Facciotti, F....
Digestive and Liver Disease.  55 (2023)  - p. S124-S125 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P570 Safety and Effectiveness of Tofacitinib in Ulcerative ..:

Macaluso, F S ; D'Antonio, E ; Fries, W...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i697-i698 , 2023
Link: https://doi.org/10.1093/..
 
?
8

P727 Effectiveness and Safety of Vedolizumab in Inflammator..:

Macaluso, F S ; Ventimiglia, M ; Orlando, A
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i857-i858 , 2023
Link: https://doi.org/10.1093/..
 
?
9

P612 Lack of seroconversion following COVID-19 vaccination,..:

Macaluso, F S ; Principi, M ; Facciotti, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i741-i741 , 2023
Link: https://doi.org/10.1093/..
 
?
10

Effectiveness and safety of 1-L PEG-ASC versus other bowel ..:

Maida, M. ; Ventimiglia, M. ; Facciorusso, A....
Digestive and Liver Disease.  55 (2023)  8 - p. 1010-1018 , 2023
Link: https://doi.org/10.1016/..
 
?
11

T.10.1 SAFETY AND EFFECTIVENESS OF TOFACITINIB IN ULCERATIV..:

Macaluso, F.S. ; D'Antonio, E. ; Fries, W....
Digestive and Liver Disease.  55 (2023)  - p. S178 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Corrigendum to "Effectiveness and safety of 1-L PEG-ASC ver..:

Maida, M. ; Ventimiglia, M. ; Facciorusso, A....
Digestive and Liver Disease.  55 (2023)  12 - p. 1782 , 2023
Link: https://doi.org/10.1016/..
 
?
13

OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS..:

Macaluso, F.S. ; Grova, M. ; Saladino, M....
Digestive and Liver Disease.  54 (2022)  - p. S93-S94 , 2022
Link: https://doi.org/10.1016/..
 
?
14

P345 The Effectiveness of Ustekinumab and Vedolizumab as Th..:

Macaluso, F S ; Grova, M ; Saladino, M...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i359-i360 , 2022
Link: https://doi.org/10.1093/..
 
?
15

T.06.10 EFFICACY AND SAFETY OF BIOSIMILARS OF ANTI-TNF-APLH..:

Dipasquale, V. ; Pellegrino, S. ; Ventimiglia, M....
Digestive and Liver Disease.  54 (2022)  - p. S141-S142 , 2022
Link: https://doi.org/10.1016/..
 
1-15